On Feb. 1, the Final Rule, titled Medicare and Medicaid Programs; Policy and Technical Changes to the Medicare Advantage, Medicare Prescription Drug Benefit, Program of AllInclusive Care for the Elderly (PACE), Medicaid Fee-For-Service, and Medicaid Managed Care Programs for Years 2020 and 2021, was published in the Federal Register.

On Jan. 22, 2024, the Department of Health and Human Services (HHS) issued a letter to Medicare plans, health insurance issuers, and State Medicaid and CHIP programs (Letter) and a set of Frequently Asked Questions (FAQs) outlining how plans and issuers can make sure they meet their contraception coverage obligations.

On January 5, 2024, the Food and Drug Administration (FDA) issued a letter authorizing the state of Florida’s Section 804 Importation Programs (SIP) proposal (Authorization Letter).

The Office of the National Coordinator for Health Information Technology (ONC) issued a final rule on Health Data, Technology, and Interoperability: Certification Program Updates, Algorithm Transparency, and Information Sharing (Final Rule), which is scheduled to be published in the Federal Register on Jan. 9, 2024.

AMCP Regulatory NewsBREAK: CMS Issues Letter to Plans and Pharmacy Benefit Managers

• On Nov. 6, 2023, the Centers for Medicare and Medicaid Services (CMS) issued a memorandum titled Application of Pharmacy Price Concessions to the Negotiated Price at the Point of Sale Beginning Jan. 1, 2024 (Memo).